Top Story
WHO warns of rising bird flu pandemic risk
The headlines may have died down in recent months, but bird flu experts say that the threat of a global pandemic has actually been growing. The World Health Organization outlined the spread of the bird flu virus around the world to 150 experts drawn together to discuss protective measures. Report
Report
Novartis reports strong meningitis vaccine response
In a head-to-head trial, researchers for Novartis say that the experimental meningitis vaccine Menveo produced a more potent immune response than the standard therapy in use. And other data has underscored that the vaccine is effective in infants not covered by the current vaccine--Menactra. Report
From the Network
Press Releases
- FDA Advisory Committee Votes in Favor of Approval of Fospropofol Disodium Injection for Sedation
- Accordance with Terms of Existing Investor Rights Agreement
- FDA Approves Strattera for Maintenance of ADHD in Children and Adolescents
- Biovail Announces New Strategic Focus
- Osiris Therapeutics Receives Approval for Use of Prochymal(TM) Under FDA Expanded Access Treatment Program
Latest Comments
Editors
About FierceVaccines
FierceVaccines gives industry insiders the latest vaccine industry news and developments. Our FREE weekly email newsletter covers the people, trends, and research projects shaping the vaccine market.
© FierceMarkets, Inc.
® All rights reserved
1319 F St NW, 6th Floor
Washington, D.C. 20004
+1.202.628.8778
www.fiercemarkets.com
Latest News
Experts call for long-term immunity tracking studies
Vaccine experts are pondering just how long vaccines will be able to provide immunity in a world where some diseases are all but eliminated and natural exposure to many common viruses has ended. Read more...
Researchers explore brain cancer vaccine
Researchers are touting the early results from a study of a new brain cancer vaccine that combines protein antigens extracted from a patient's tumor and matches them with white cells also drawn from Read more...
VaxGen sells anthrax vaccine to its old rival
Reduced to a skeleton crew and a bleak outlook, South San Francisco-based VaxGen sold its experimental anthrax vaccine to its former chief rival, Emergent BioSolutions, for $2 million down and up to Read more...
SPOTLIGHT: Covance wins CRO award
Covance, the inaugural sponsor of FierceVaccines, was recognized as the Best CRO at the 2008 World Vaccine Congress. The award recognizes for providing services that support vaccine development. Read more...
ALSO NOTED: Vaccine benefits studied; Menveo wins head-to-head study;and much more...
Vaccine Market Harvard economist Dr. David E. Bloom has studied the economic impact of an effective national program for vaccinations, outlining how better health improves a person's wealth. Read more...
FDA orders Merck to fix vaccine plant problems
The FDA has given Merck 15 days to decide how to fix Read more...
Discovery offers shortcut to custom flu vaccines
A team of researchers at Emory University and the Oklahoma Medical Research Foundation has found a way to radically upend the way new vaccines are developed to fight a pandemic. Just days after a Read more...
Many infants don't get vaccinations on time
A large group of American parents are having a tough time keeping up with their kids' vaccination schedules. More than a quarter of all children are under-vaccinated, with missed doses accounting Read more...
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight